Citations

Clear

116 citation(s) found for "Colby, Thomas".

Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma
Ochkur, Sergei I. , Jacobsen, Elizabeth A. , Protheroe, Cheryl, Biechele, Travis L., Pero, Ralph, McGarry, Michael P. , O'Neill, K.R. , Colbert, Dana, Colby, Thomas V. , Shen, Huahao , Irvin, Charles, Lee, James J. , Lee, Nancy A., Wang, Huiying , Blackburn, Michael R. , Jacobsen, Elizabeth A

Mayo Clinic

The Journal of Immunology | April 18, 2014 | Volume: 178 | Issue: 12 | Pages: 7879-7889

10.4049/jimmunol.178.12.7879 | PMID 17548626 Get It

Abstract Mouse models of allergen provocation and/or transgenic gene expression have provided significant insights regarding the cellular, molecular, and immune responses linked to the pathologies occurring as a result of allergic respiratory inflammation. Nonetheless, the inability to replicate the eosinophil activities occurring in patients with asthma has limited their usefulness to understand the larger role(s) of eosinophils in disease pathologies. These limitations have led us to develop an allergen-naive double transgenic mouse model that expresses IL-5 systemically from mature T cells and eotaxin-2 locally from lung epithelial cells. We show that these mice develop several pulmonary pathologies representative of severe asthma, including structural remodeling events such as epithelial desquamation and mucus hypersecretion leading to airway obstruction, subepithelial fibrosis, airway smooth muscle hyperplasia, and pathophysiological changes exemplified by exacerbated methacholine-induced airway hyperresponsiveness. More importantly, and similar to human patients, the pulmonary pathologies observed are accompanied by extensive eosinophil degranulation. Genetic ablation of all eosinophils from this double transgenic model abolished the induced pulmonary pathologies, demonstrating that these pathologies are a consequence of one or more eosinophil effector functions.
Reply: Characterization of Lymphangioleiomyomatosis as a Neoplastic Disease
McCormack, Francis X. , Colby, Thomas V. , Moss, Joel, Мirrakhimov, Erkin М , Travis, William D. , Henske, Elizabeth P. , McCormack, Francis X

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | August 1, 2013 | Volume: 188 | Issue: 3 | Pages: 398-399

10.1164/rccm.201301-0199le | PMID 23905529 Get It

Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia and centrilobular emphysema
Yamada, Tsutomu , Nakanishi, Yoko , Homma, Taku , Uehara, Kenji, Mizutani, Tomohiko, Hoshi, Eishin, Shimizu, Yoshihiko, Kawabata, Yoshinori , Colby, Thomas V.

Mayo Clinic

Pathology International | May 21, 2013 | Volume: 63 | Issue: 4 | Pages: 206-213

10.1111/pin.12054 | PMID 23692421 Get It

The histologic characteristics of air space enlargement with fibrosis (AEF) are compared with usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP) and centrilobular emphysema (CLE) to determine similarities and differences. Lung specimens from 39 patients were studied; 9 with AEF, 13 with UIP and 5 with CLE identified in lobectomy specimens for cancer and 12 NSIP cases identified on surgical lung biopsies. We determined the characteristics of cystic structures (i.e. abnormal airspace), degree of inflammation and severity of pneumocyte injury semi‐quantitatively. In AEF, the wall thickness of the cystic lesions (0.8 mm) was thinner than in UIP (2.1 mm) and thicker than in CLE (0.07 mm). The degree of inflammation and granulation tissue were milder in AEF than in UIP and NSIP and CLE showed milder inflammatory cells than AEF. As for pneumocyte injury, AEF had fewer erosions (0.1/case) and fewer ubiquitin‐positive pneumocytes than UIP (4.8 cells/slide) and NSIP (9.8 cells/slide). Our data suggested that the histological characteristics of AEF differed significantly from UIP, NSIP and CLE.
Clinical Significance of Serum Autoantibodies in Idiopathic Interstitial Pneumonia
Kang, Bo Hyoung , Park, Jin Kyeong, Roh, Jae‐Hyung , Song, Jin Woo , Lee, Chang Keun, Jang, Se Jin , Colby, Thomas V. , Kim, Dong Soon, Kim, Miyoung

Mayo Clinic

Journal of Korean Medical Science | May 9, 2013 | Volume: 28 | Issue: 5 | Pages: 731

10.3346/jkms.2013.28.5.731 | PMID 23678265 Get It

UIP Diagnosed at Surgical Lung Biopsy, 2000–2009: HRCT Patterns and Proposed Classification System
Gruden, James F. , Panse, Prasad M., Leslie, Kevin O., Tazelaar, Henry D. , Colby, Thomas V. , Tazelaar, Henry D.

Mayo Clinic

American Journal of Roentgenology | April 25, 2013 | Volume: 200 | Issue: 5 | Pages: W458-W467

10.2214/ajr.12.9437 | PMID 23617514 Get It

Tissue Localization of Transforming Growth Factor-Beta1 in Pulmonary Eosinophilic Granuloma
Asakura, S, Colby, Thomas V. , Limper, Andrew H.

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 154 | Issue: 5 | Pages: 1525-1530

10.1164/ajrccm.154.5.8912775 | PMID 8912775 Get It

Abstract Pulmonary eosinophilic granuloma is characterized by infiltration of the lungs with fibronodular lesions containing specialized Langerhans' cells. In some patients, progressive pulmonary fibrosis leads to significant respiratory impairment. Transforming growth factor-beta1 (TGF-beta1) promotes fibrosis by enhancing the synthesis of extracellular matrix components. The role of TGF-beta1 in promoting fibrosis in the setting of pulmonary eosinophilic granuloma is currently unknown. We used immunohistochemistry to evaluate the extent and distribution of TGF-beta1 and the extracellular matrix components type I collagen and decorin, a TGF-beta1-binding proteoglycan. Lung biopsies from 11 patients with pulmonary eosinophilic granuloma were evaluated. In biopsies with active inflammatory lesions containing Langerhans' cells, hyperplastic type 2 pneumocytes and alveolar macrophages within and surrounding the fibronodular lesions contained abundant TGF-beta1. Langerhans' cells were consistently devoid of immunoreactive TGF-beta1. Active inflammatory lesions also exhibited staining for decorin, in a loosely organized distribution. Advanced fibrotic lesions of eosinophilic granuloma, containing minimal inflammatory cells and few or no Langerhans' cells, exhibited weak or absent staining for TGF-beta1 within either hyperplastic type 2 pneumocytes or alveolar macrophages. The fibroconnective tissues of these advanced fibrotic lesions consistently revealed dense staining for decorin. Through their actions on extracellular matrix protein accumulation, TGF-beta1 and the TGF-beta1-binding proteoglycan decorin may modulate fibrotic repair accompanying pulmonary eosinophilic granuloma.
Acute Eosinophilic Pneumonia: Histopathologic Findings in Nine Patients
Tazelaar, Henry D. , Lin-z, Long, Colby, Thomas V. , Tazelaar, Henry D. , Myers, Jeffrey L. , Limper, Andrew H.

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 155 | Issue: 1 | Pages: 296-302

10.1164/ajrccm.155.1.9001328 | PMID 9001328 Get It

Abstract Acute eosinophilic pneumonia is characterized by acute respiratory insufficiency, hypoxemia, fever, diffuse radiographic infiltrates, and eosinophilia in bronchoalveolar lavage fluid (BALF) or lung biopsies in the absence of infection, atopy, or asthma. A rapid response to corticosteroids is characteristic. We reviewed our experience with nine cases of acute lung disease with histologic features of acute and organizing diffuse alveolar damage and prominent interstitial and alveolar eosinophils in order to determine whether this pathology was characteristic of acute eosinophilic pneumonia. The mean age of the patients (four men and five women) was 53 yr (range: 33 to 71 yr). They presented with 2 to 21 d of dyspnea, cough, myalgias, and fever. All were hypoxic and had bilateral infiltrates on chest radiographs. Peripheral blood eosinophilia was present in four of eight patients (peripheral blood count unavailable for one patient). All patients were treated with high-dose corticosteroids with a mean time to symptomatic and radiographic improvement of 4 d. Seven of the nine patients enrolled in the study are alive without relapse; one patient has a mild deficit in diffusing capacity, and one patient died of a myocardial infarct while improving on therapy. The presence of eosinophils in cases of acute respiratory insufficiency due to diffuse alveolar damage (DAD) should suggest the diagnostic possibility of acute eosinophilic pneumonia. Acute eosinophilic pneumonia should be distinguished from other causes of DAD because of important differences in natural history.
Correlation of Structure and Function in Idiopathic Pulmonary Fibrosis
Cherniack, Reuben M., Colby, Thomas V. , Flint, Andrew , Thurlbeck, William M., Waldron, James A., Ackerson, Lynn, Schwarz, Marvin I., King, Talmadge E.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 151 | Issue: 4 | Pages: 1180-1188

10.1164/ajrccm/151.4.1180 | PMID 7697250 Get It

Abstract The early stage of idiopathic pulmonary fibrosis (IPF) is thought to involve a smaller number of alveoli and to be characterized predominantly by cellularity and minimal fibrosis, whereas advanced disease involves a large number of alveoli and is characterized predominantly by fibrosis with minimal cellularity. In addition, correlative studies have indicated that prognosis and response to therapy is determined in part by the extent of fibrosis and cellularity. This study was undertaken to determine whether pulmonary function assessment would help distinguish between the cellular and fibrotic phases of this disorder, as determined by a semiquantitative pathology scoring system that comprised four factor scores: fibrosis, cellularity, granulation/connective tissue, and desquamation. Ninety-six untreated patients with biopsy-confirmed IPF (27 never smokers, 32 current smokers, and 37 ex-smokers) were evaluated. In the group as a whole, there was no significant relationship between the fibrosis or the connective/granulation tissue factor scores and any of the physiologic parameters. The Dl co correlated with the “desquamation” and the total pathology scores, whereas the TLC and FVC correlated with the cellularity factor score. In the current smokers, the coefficient of elastic retraction, Dl co/Va, and FEV1/FVC ratio were significantly lower than in never smokers and ex-smokers, and TLC and FVC were higher than in never smokers. Also, the mean cellularity and granulation/connective tissue factor scores were significantly lower, and the desquamation factor score was significantly higher than those in never smokers and ex-smokers. Both age and smoking status were significant for the cellularity factor score, whereas for the connective/granulation tissue factor score, age was not significant but smoking status was. For the desquamation factor score, age was significant but smoking status was not. There were significant differences between never smokers and ever smokers in the relationship between the pathology factors and measurements of respiratory function, and this may explain some of the difficulty in assessing structure-function correlation in patients with IPF. In the never smokers, the correlations between structure and function were likely the direct result of IPF per se. In the current smokers, bronchiolar and/or emphysematous changes associated with cigarette smoking may have complicated the pathologic alterations caused by IPF, as well as influencing the functional derangements.
Tracheobronchial Involvement in Wegener's Granulomatosis
Daum, Timothy E., Specks, U., Colby, Thomas V. , Edell, Eric S. , Brutinel, M., Prakash, Udaya B. S., DeRemee, Richard A., Specks, Ulrich

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 151 | Issue: 2 | Pages: 522-526

10.1164/ajrccm.151.2.7842215 | PMID 7842215 Get It

Abstract This study was designed to characterize the clinical spectrum and course of tracheobronchial involvement in Wegener's granulomatosis (WG). Of the 51 patients with biopsy-proven WG who underwent bronchoscopy at least once at our institution between January 1982 and November 1993, 30 (59%) had endobronchial abnormalities due to WG. Initial findings included subglottic stenosis in five (17%), ulcerating tracheobronchitis with or without inflammatory pseudotumors in 18 (60%), tracheal or bronchial stenosis without inflammation in four (13%), and hemorrhage without identifiable source in two (4%) patients. Nine patients with ulcerating tracheobronchitis on initial study had subsequent bronchoscopies for continued symptoms, which in seven cases documented the progression from ulcerating tracheobronchitis to stenosis without inflammation. Bronchoscopic interventions included dilation by rigid bronchoscope in three, YAG-laser treatment in one, and placement of silastic airway stents in three patients. Only the stents provided persistent airway patency. Endobronchial biopsies were performed on 21 occasions in 17 patients. Half of the specimens were helpful in establishing the diagnosis and in all but three in assessing disease activity. While antineutrophil cytoplasmic antibody titers reflect overall disease activity, no correlation with endobronchial inflammatory activity was apparent.
Immunohistochemical Localization of Transforming Growth Factor-Beta 1 in the Nonnecrotizing Granulomas of Pulmonary Sarcoidosis
Colby, Thomas V. , Sanders, Madeline , Asakura, S, Roche, Patrick C. , DeRemee, Richard A., Limper, Andrew H.

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 149 | Issue: 1 | Pages: 197-204

10.1164/ajrccm.149.1.8111583 | PMID 8111583 Get It

Abstract Sarcoidosis is a chronic inflammatory disease of unknown cause characterized by the formation of nonnecrotizing granulomas in affected tissues, most notably the lungs. Granuloma healing may result in pulmonary fibrosis and respiratory impairment in some patients. Transforming growth factor-beta 1 (TGF-beta 1) is a potent cytokine that promotes fibrosis by enhancing the synthesis of extracellular matrix components, including fibronectin and the alpha 5 beta 1 fibronectin receptor. The role of TGF-beta 1 in promoting lung fibrosis in the setting of pulmonary sarcoidosis has not yet been investigated. Accordingly, we determined the extent and distribution of TGF-beta 1 in lung tissue obtained from seven patients with clinical and histologic features of pulmonary sarcoidosis. The tissue distributions of TGF-beta 1, the TGF-beta 1 binding proteoglycan decorin, fibronectin, and the alpha 5 beta 1 fibronectin receptor were assessed immunohistochemically. In all cases, the epithelioid histiocytes comprising nonnecrotizing granulomas of pulmonary sarcoidosis contained abundant TGF-beta 1. We further demonstrated decorin, fibronectin, and the alpha 5 beta 1 fibronectin receptor within nonnecrotizing granulomas and in the fibrous tissue surrounding the lesions. TGF-beta 1 staining was also observed in bronchiolar epithelial cells, hyperplastic Type II pneumocytes, and occasional alveolar macrophages. This study demonstrates enhanced tissue localization of TGF-beta 1 and related extracellular matrix proteins associated with the nonnecrotizing granulomas of pulmonary sarcoidosis. Through its actions on matrix protein synthesis, TGF-beta 1 may modulate the fibrotic repair process accompanying granuloma healing in sarcoidosis.